ReviewHerz2026
[Cardiovascular imaging using cardiac computed tomography and cardiac magnetic resonance imaging].
Review in Herz, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Noninvasive cardiac imaging using cardiac computed tomography (CCT) and cardiac magnetic resonance imaging (CMRI) has become established as an indispensable diagnostic instrument in modern cardiology for the assessment of cardiovascular diseases. Both techniques are complementary in their diagnostic potential and enable an individualized clinical care, including diagnostic confirmation, prognosis estimation and treatment planning. The use of CCT enables a precise visualization of the coronary vessels, including the detection and quantification of luminal stenosis and additional plaque characterization. It is particularly suitable for the noninvasive clarification of coronary artery disease (CAD) in patients with a low to moderate pretest probability and for procedural planning in cardiology. The high negative predictive value of CCT enables its use as a gatekeeper for unnecessary invasive diagnostics of CAD. The use of CMRI provides a combination of functional morphological diagnostics with a precise myocardial tissue characterization, which are helpful for the assessment of CAD, inflammatory heart diseases and cardiomyopathies. Due to the possibility to quantify myocardial damage, CMRI has a high prognostic value. The combination of both non-invasive techniques in the present-day modern cardiac diagnostics is essential for guideline-compliant and patient-centered care by the coverage of the broad spectrum of cardiac diseases and the supplementary methods.
Indexed as
Identifiers
41335216What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.